Internal Medicine, Hematology · Boston, MA
NPI
1417168055
Since 2007
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
55 Fruit St
Boston, MA, 02114
Phone (650) 224-0183
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
172 services
Medicare patients, 2024
47
Average age 73
Drug cost, 2024
$1.4M
254 prescriptions
Company payments, 2025
$4,247
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Salvia S Jain was code 99215 (office e&m - established), 133 times for 41 patients. In total Salvia S Jain billed 172 services in 5 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 133 | 41 | $115.75 | $15K |
By year: 2022 $14K for 136 services; 2023 $27K for 245 services; 2024 $20K for 172 services.
Medicare prescription drug claims, 2024
In 2024, the drug Salvia S Jain prescribed most often to Medicare patients was Prednisone, with 34 prescriptions and refills. In total Salvia S Jain wrote 254 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 34 | 38 | Under 11 | $96.68 |
| Acyclovir Generic | 33 | 68 | 13 | $803 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 20 | 31 | Under 11 | $98.13 |
| Copiktra Duvelisib | 15 | 15 | Under 11 | $1.1M |
| Atovaquone Generic | 14 | 14 | Under 11 | $12K |
Brand drugs: 42 claims; generic drugs: 212 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salvia S Jain $4,247 ($4,247 in general payments such as food, travel and fees) from 4 companies. The largest payer was Acrotech Biopharma Inc. with $3,994.
| Company | Payments | Amount |
|---|---|---|
| Acrotech Biopharma Inc. | 7 | $3,994 |
| Pfizer Inc. PFE | 1 | $144 |
| Secura Bio, Inc. | 1 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.